SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-001569
Filing Date
2022-01-11
Accepted
2022-01-11 15:33:21
Documents
2
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1641
2 EX-24 DOCUMENT attachment1.htm EX-24 3384
  Complete submission text file 0000899243-22-001569.txt   6388
Mailing Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201
Business Address 1717 MAIN STREET SUITE 3388 DALLAS TX 75201 (254) 244-5739
Vaxxinity, Inc. (Issuer) CIK: 0001851657 (see all company filings)

IRS No.: 862083865 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VAXXINITY, INC. 1717 MAIN ST. STE.3388 DALLAS TX 75201
Business Address
Pesile Jason (Reporting) CIK: 0001903670 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41058 | Film No.: 22523782